Table 1 Incidence, case finding methods and diagnostic criteria of subarachnoid haemorrhage in newly identified study periods and regions*
Study populationRegionMidyear of studyNo of patient-yearsNo of SAH patientsIncidence per 100 000 person years (95% CI)Additional case finding methods‡% of patients with CTAdditional diagnostic criteria††
Rochester39USA1955331 081298.8 (5.9 to 12.6)adhjm0AB
Rochester39USA1965451 6115211.5 (8.6 to 15.1)adhjm0AB
Espoo17Finland1972226 2004218.6 (13.4 to 25.1)ae0B
Rochester39USA1975543 5616111.2 (8.6 to 14.4)adhjm27¶ABD
Espoo17Finland1979273 7003312.1 (8.3 to 16.9)ae11B
Copenhagen46Denmark1984295 4704916.6 (12.3 to 21.9)ak47ABE
Izumo city†27Japan1985807 49017021.1 (18.0 to 24.5)a99§ABC
Rochester39USA1985617 554437.0 (5.0 to 9.4)adhjm85¶ABD
Finland17Finland1990269 6083914.5 (10.3 to 19.8)aeh60B
Izumo city†26Japan1990496 07412324.8 (20.6 to 29.6)ai100§BE
Asturias37Spain1991417 033286.7 (4.5 to 9.7)b70‡‡
Ahmadi29Kuwait1992291 19941.4 (0.4 to 35.2)ab100A
Novosibirsk35Russia1992158 234148.9 (4.8 to 14.8)abehjm0**BC
Auckland†31New Zealand19921 890 7381668.8 (7.5 to 10.2)ae82ABC
Belluno22Italy1992211 389125.7 (2.9 to 9.9)abefjk90AB
Sweden north42Sweden19938 212 80098412.0 (11.2 to 12.8)abkh87ABC
L’Aquila21Italy1994297 838248.0 (5.2 to 12.0)abcefj89¶AB
Shimokita†24Japan1994899 91019822.0 (19.0 to 25.3)ai100§AC
Izumo City25Japan1994509 12412324.2 (20.1 to 28.8)ai98ABC
Malmo45Sweden19952 674 1441977.4 (6.4 to 8.5)abde89AB
Izumo city†27Japan1995763 68618824.7 (21.2 to 28.4)ai98ABC
Perth7Australia1995134 00043.0 (0.8 to 7.6)abdfj>78BC
Sweden south40Sweden19961 140 0001069.3 (7.6 to 11.2)ai100¶ABC
Melbourne5Australia1996133 816129.0 (4.6 to 15.7)bdg91¶AB
London11UK1996938 132747.9 (6.2 to 9.9)abefj88¶AB
Vibo Valentia20Italy1996179 186126.7 (3.5 to 11.7)abdejk96¶B
Dijon43France1996429 264122.8 (1.4 to 4.9)abdeh96‡‡
Valle d’ Aosta44Italy1997118 7231411.8 (6.4 to 19.8)abdej97¶AB
Erlangen10Germany1997202 900125.9 (3.1 to 10.3)abdejk96D
Kumamoto†23Japan19989 300 000211522.7 (21.8 to 23.7)bij100§AC
Martinique30Caribbean1998360 000205.6 (3.4 to 8.6)abeijk93A
Scotland36UK1999212 7042310.8 (6.9 to 16.2)abhfl91B
Portugal north33Portugal1999246 224239.3 (5.9 to 14.0)abdefhikm97B
Orebro41Sweden1999123 503118.9 (4.4 to 15.9)abdefkm84AB
Tartu13Estonia2000101 12287.9 (3.4 to 15.6)abei92B
Iqueque9Chile2001396 712153.8 (2.1 to 6.2)abdefgh91AB
Tbilisi18Georgia2002140 9262316.3 (10.3 to 24.5)aehijl78§A
Barbados8Caribbean2002239 06872.9 (1.2 to 6.0)abcdefh96B
Oxford12UK2003181 084168.8 (5.1 to 14.3)abefk98¶AB
  • SAH, subarachnoid haemorrhage.

  • *Studies listed in ascending order of midyear of data collection and are additional to those in the previous review.

  • †Studies based primarily on SAH, in contrast with general stroke studies.

  • ‡Case finding methods. For inclusion, involvement of all hospitals in the region necessary and at least a or b. a = death certificates; b = general practitioners; c = rehabilitation; d = nursing homes; e = regular search; f = review radiology requests; g = media attention (campaign/newspaper); h = outpatient clinics, health centres; i = sudden deaths, very early death; j = emergency, ambulance, on call medical services; k = ICD-codes; l = door-to-door, home visit, social services, phone calls; m = autopsy reports.

  • §Studies providing the proportion of CT use in SAH patients exclusively, in contrast with % of CT in patients with stroke in general.

  • ¶Studies not providing the exact proportion of patients with CT exclusively, but only the proportion of patients investigated with CT, autopsy or MRI.

  • **CT was available after 1992, and before 1992, all patients were diagnosed with lumbar puncture or autopsy.

  • ††Additional diagnostic criteria, besides CT. For inclusion, at least A or B was necessary in pre-CT era or when CT percentage was below 90%. A = Lumbar puncture; B = autopsy; C = angiography; D = MRI; E = surgery.

  • ‡‡Proportion of patients investigated with CT or diagnostic criteria unknown, but inclusion after discussion among authors of this review.